Abstracts Archive - Page 1795 of 2425 - ACR Meeting Abstracts

Abstract Number: 1589 • 2015 ACR/ARHP Annual Meeting
Impact of Osteoarthritis of the Hand on Disease Activity Scores and Health Status in Patients with Rheumatoid Arthritis
Hector Fabricio Espinosa Ortega¹, Cesar Alejandro Arce Salinas² and Emmanuel Ruiz Medrano³, ¹Rheumatology, Hospital Central Sur Alta Especialidad Pemex, Mexico City, Mexico, ²Rheumatology, Hospital Central Sur de Alta Especialidad Pemex, Mexico, Mexico, ³Hospital Central Sur de Alta Especialidad Pemex, Mexico, Mexico
Background/Purpose: Rheumatoid arthritis (RA) is a polyarticular autoimmune inflammatory disease characterized for pain, joint edema and functional limitation. Some items in evaluation could be affected…
Abstract Number: 1590 • 2015 ACR/ARHP Annual Meeting
Rheumatoid Arthritis-Related Interstitial Lung Disease (RA-ILD): Methotrexate and the Extension of Lung Disease Are Associated to Prognosis
Jorge Rojas-Serrano¹, Denisse Herrera-Bringas², Renzo Perez-Dorame³, Mayra Mejia² and Heidegger Mateos-Toledo⁴, ¹Interstitial Lung Diseases Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico, ²Interstitial Lung Diseases Unit, Insituto Nacional de Enfermedades Respiratorias, Mexico, Mexico, ³Intertitial Lung Disease Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico, Mexico, ⁴Interstitial Lung Diseases Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico, Mexico
Background/Purpose:Interstitial lung disease (ILD) is a severe rheumatoid arthritis manifestation with a median survival of 2.6 years. Worst survival has been associated to usual interstitial…
Abstract Number: 1591 • 2015 ACR/ARHP Annual Meeting
A Low Adiponectin Level in Rheumatoid Arthritis Is Associated with Coronary Artery Disease
Jon Roger Eidet¹, Ida G. Fostad², Kelly J. Shields³, Torstein Lyberg¹, Tor Paaske Utheim¹, Anita Kåss⁴, Knut Mikkelsen⁵, Terje Veel⁶, Kjell Saatvedt⁷, Morten Wang Fagerland⁸, Matthew Liang⁹ and Ivana Hollan⁵, ¹Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway, ²Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway, ³Medicine, Lupus Center of Excellence / Allegheny Health Network, Pittsburgh, PA, ⁴Rheumatology, Betanien Hospital, Skien, Norway, ⁵Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, ⁶Department of Cardiac Surgery, Feiring Heart Clinic, Feiring, Norway, ⁷Department of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway, ⁸Department of Biostatistics, Oslo University Hospital, Oslo, Norway, ⁹Department of Rheumatology, Brigham and Women’ s Hospital, Boston, Boston, MA
Background/Purpose: Adipokines exert pleiotropic actions, including immunoregulatory and matrix degrading effects. There is evidence of adipokine involvement in the pathogenesis of cardiovascular (CV) disease as…
Abstract Number: 1592 • 2015 ACR/ARHP Annual Meeting
Sex Differences in Cardiovascular Risk Factors and Event Rates in Patients with Rheumatoid Arthritis – Data from 13 Rheumatology Centers
Silvia Rollefstad¹, Eirik Ikdahl¹, Cynthia S. Crowson², Sherine Gabriel³, George D. Kitas⁴, Piet L van Riel⁵, Anne Grete Semb⁶ and ATACC-RA, ¹Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Health Sciences Research, Mayo Clinic, Rochester, MN, ³Division of Rheumatology; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴The Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, ⁵Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, Netherlands, ⁶Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose: Patients with rheumatoid arthritis (RA) have an excess risk of cardiovascular disease (CVD). There is a clear female to male preponderance of RA. In…
Abstract Number: 1593 • 2015 ACR/ARHP Annual Meeting
Telomere Length and Cardiovascular Risk in Rheumatoid Arthritis
Michelle J. Ormseth¹, Joseph F. Solus², Annette M. Oeser³, Aihua Bian⁴, Tebeb Gebretsadik⁴, Ayumi Shintani⁵, Paolo Raggi⁶ and C Michael Stein⁵, ¹Department of Medicine, Division of Rheumatology, Vanderbilt University, Nashville, TN, ²Clinical Pharmacology, Vanderbilt University, Nashville, TN, ³Medicine, Vanderbilt University, Nashville, TN, ⁴Biostatistics, Vanderbilt University, Nashville, TN, ⁵Vanderbilt University, Nashville, TN, ⁶Emory University, Atlanta, GA
Background/Purpose: Telomeres protect against DNA damage and shorten with each cell division; their length may be a marker of cardiovascular and overall biological aging. Patients…
Abstract Number: 1594 • 2015 ACR/ARHP Annual Meeting
No Association of Anti-Citrullinated Peptide Antibodies with Coronary Artery Calcification in Two Rheumatoid Arthritis Cohorts without Clinical Cardiovascular Disease
Laura Geraldino-Pardilla¹, Jon T. Giles², Jeremy Sokolove³, Afshin Zartoshti⁴, WH Robinson⁵ and Joan M. Bathon⁶, ¹Division of Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, ²Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, ³Medicine, VA Palo Alto HealthCare System and Stanford University, Palo Alto, CA, ⁴Rheumatology, Columbia University Medical Center, NY, NY, ⁵Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, ⁶Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY
Background/Purpose: Citrullinated proteins have been found in atherosclerotic plaques. However, contradictory results currently exist regarding the association of anti-citrullinated peptide antibodies (ACPAs) with coronary artery…
Abstract Number: 1595 • 2015 ACR/ARHP Annual Meeting
Impaired Coronary Flow Reserve in Rheumatoid Arthritis: A Robust Indicator of Cardiac Structure Associated with Systemic Inflammation and Rheumatoid Arthritis Treatments
Isabelle Amigues¹, Jon T. Giles¹, Sabahat Bokhari², Afshin Zartoshti³, Richard Weinberg², Cesare Russo⁴ and Joan Bathon³, ¹Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, ²Cardiology, Columbia University Medical Center, NY, NY, ³Rheumatology, Columbia University Medical Center, NY, NY, ⁴Division of Cardiology, Columbia University, College of Physicians & Surgeons, New York, NY
Background/Purpose: Myocardial microvascular dysfunction may precede or coexist with coronary atherosclerosis and heart failure, two conditions over-represented in RA. Coronary flow reserve (CFR) offers an…
Abstract Number: 1596 • 2015 ACR/ARHP Annual Meeting
Diagnosis of Carotid Plaque By 4 Cardiovascular Risk Scores in Rheumatoid Arthritis
Raymundo Vera-Pineda¹, Alberto Cardenas-de La Garza², Dionicio A. Galarza-Delgado², Jose Ramon Azpiri-Lopez³, Iris J. Colunga-Pedraza², Judith Garcia-Colunga⁴, Guillermo Elizondo⁴, Mario Alberto Garza-Elizondo², Jesus Zacarias Villarreal-Pérez⁵ and Griselda Serna-Peña⁶, ¹Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, ²Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ³Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, ⁴Radiology, Hospital Universitario, UANL., Monterrey, Mexico, ⁵Endocrinology, Hospital Universitario, UANL., Monterrey, Mexico, ⁶Internal Medicine, Hospital Universitario, UANL., Monterrey, Mexico
Background/Purpose: The leading cause of death in RA is atherosclerotic cardiovascular disease (ASCVD). Traditional risk factors do not explain the increased cardiovascular risk (CVR), which…
Abstract Number: 1597 • 2015 ACR/ARHP Annual Meeting
Variability in Health Assessment Questionnaire Based on Type of Health Insurance Coverage and Rheumatology Practice
Jacqueline Stewart¹, Regan Arendse², Boulos Haraoui³, Michael Starr⁴, Denis Choquette⁵, Michelle Teo⁶, Dalton Sholter⁷, Emmanouil Rampakakis⁸, Eliofotisti Psaradellis⁹, Brendan Osborne¹⁰, Karina Maslova¹¹, Cathy Tkaczyk¹⁰, Francois Nantel¹² and Allen J Lehman¹¹, ¹Penticton Regional Hospital, Penticton, BC, Canada, ²University of Saskatchewan, Saskatoon, SK, Canada, ³Institut de Rhumatologie de Montréal and University of Montreal, Montreal, QC, Canada, ⁴Rheumatology, McGill University, Montreal, QC, Canada, ⁵Rheumatology Department, Institut de Rhumatologie de Montréal and University of Montreal, Montreal, QC, Canada, ⁶Rheumatology, Penticton Regional Hospital, Penticton, BC, Canada, ⁷Rheumatology Associates, Edmonton, AB, Canada, ⁸JSS Medical Research, St-Laurent, QC, Canada, ⁹JSS Medical Research, Montreal, QC, Canada, ¹⁰Medical Affairs, Janssen Inc., Toronto, ON, Canada, ¹¹Janssen Inc., Toronto, ON, Canada, ¹²19 Green belt Dr, Janssen Inc., Toronto, ON, Canada
Background/Purpose : Previous studies in rheumatoid arthritis (RA) have shown that patient socioeconomic status (SES) impacts patient prognosis. We hypothesized that public vs. private healthcare…
Abstract Number: 1598 • 2015 ACR/ARHP Annual Meeting
Obesity and the Risk for Development of Rheumatoid Arthritis – Results from a Population-Based Nested Case-Control Study
Lotta Ljung^1,2 and Solbritt Rantapää-Dahlqvist³, ¹Department of Medicine, Solna, Clinical epidemiology unit, Karolinska Institutet, Stockholm, Sweden, ²Department for Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, ³Department for Public Health and Clinical Medicine/ Rheumatology, Umeå University, Umeå, Sweden
Background/Purpose: Studies on obesity and the risk for development of rheumatoid arthritis (RA) have shown diverse results. In this study we evaluated the association between…
Abstract Number: 1599 • 2015 ACR/ARHP Annual Meeting
Clinical Characteristics of Interstitial Lung Disease (ILD) in Rheumatoid Arthritis (RA) Patients in High Resolutional CT (HRCT) and Titer of Anti Citrullinated Peptide Antibodies (anti-CCP2)
Masaomi Yamasaki, Rheumatology, Shin-Yokohama Arthritis and Rheumatology Clinic, Yokohama, Japan
Background/Purpose: To investigate clinical characteristics of interstitial lung disease (ILD) in rheumatoid arthritis (RA) patients. And to analyze whether high resolutional CT (HRCT) and anti…
Abstract Number: 1600 • 2015 ACR/ARHP Annual Meeting
Pulmonary Manifestations in Early Rheumatoid Arthritis: A 6 Month Follow up Study
Gudrun Reynisdottir¹, Helga Olsen², Johan Grunewald², Magnus Skold², Anders Eklund³ and Anca I Catrina⁴, ¹Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, ²Department of Medicine, Division of Respiratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, ³Division of Respiratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, ⁴Unit of Rheumatology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Pulmonary manifestations are common in rheumatoid arthritis (RA). However, limited information is available concerning the early development of such manifestations in newly diagnosed patients.…
Abstract Number: 1601 • 2015 ACR/ARHP Annual Meeting
Evaluation of Glucose Metabolism in Rheumatic Patients: A Case Control Study
Mattia Bellan¹, Simone Bor², Roberta Pedrazzoli³, Daniele Sola², Antonello Gibbin², Giulia Guaschino², Alessandro Gualerzi², Serena Favretto², Mirta Menegatti², Gian Piero Carnevale Schianca³, Mario Pirisi² and Pier Paolo Sainaghi³, ¹Department of Translational Medicine, Università del Piemonte Orientale UPO, Novara, Italy, ²Università del Piemonte Orientale UPO, Novara, Italy, ³Division of Internal Medicine, Immuno-rheumatology Unit, "Maggiore della Carità" Hospital, Novara, Italy
Background/Purpose: Whether glucose metabolism is abnormal in patients affected by inflammatory arthritis is controversial. In the present study, we aimed to evaluate glucose metabolism in…
Abstract Number: 1602 • 2015 ACR/ARHP Annual Meeting
Beta Cells Function and Insulin Resistance during Tocilizumab Treatment in Non-Diabetic RA Patients: Results from a Single-Center Study
Gorica Ristic¹, Vesna Subota², Petar Ristic³, Dejana Stanisavljevic⁴, Arsen Ristic⁵, Branislava Glisic¹, Milan Petronijevic¹ and Dusan Stefanovic¹, ¹Department of Rheumatology and Clinical Immunology, Military Medical Academy, Belgrade, Serbia, ²Institute of Medical Biochemistry, Military Medical Academy, Belgrade, Serbia, ³Department of Endocrinology, Military Medical Academy, Belgrade, Serbia, ⁴Institute of Medical Statistics, Belgrade University School of Medicine, Belgrade, Serbia, ⁵Department of Cardiology, Clinical Center of Serbia & Belgrade University School of Medicine, Belgrade, Serbia
Background/Purpose: Insulin resistance (IR) is increased and β-cell function impaired in rheumatoid arthritis (RA). The aim of this study was to evaluate whether treatment with…
Abstract Number: 1603 • 2015 ACR/ARHP Annual Meeting
Safety of Biologic and Non-Biologic Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Veterans with Rheumatoid Arthritis and Chronic Hepatitis C Infection
Jeffrey R. Curtis^1,2, Mary Jane Burton³, Shou Yang¹, Lang Chen¹, Ted R. Mikuls⁴, Jasvinder A. Singh², Kevin L. Winthrop⁵ and John Baddley^2,6, ¹University of Alabama at Birmingham, Birmingham, AL, ²Birmingham VAMC, Birmingham, AL, ³Jackson VAMC, Jackson, MS, ⁴University of Nebraska Medical Center, Omaha, NE, ⁵Oregon Health and Science University, Portland, OR, ⁶Medicine, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Among patients with rheumatoid arthritis and hepatitis C virus (HCV) infection, the impact of biologic and nonbiologic DMARD therapy on hepatotoxicity has received limited study.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].